1947 — Meihao Medical Co Income Statement
0.000.00%
- HK$167.63m
- HK$119.53m
- CNY74.68m
Annual income statement for Meihao Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 84.6 | 105 | 127 | 73.5 | 74.7 |
Cost of Revenue | |||||
Gross Profit | 50.6 | 66.9 | 78.2 | 32.7 | 27 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 58.5 | 59.2 | 85.3 | 79 | 103 |
Operating Profit | 26 | 46.1 | 42.1 | -5.53 | -28.5 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 24.2 | 43.7 | 40.2 | -7.16 | -30.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15 | 32.2 | 28.6 | -13.6 | -32.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 14.9 | 32.1 | 28.5 | -13.6 | -32.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 14.9 | 32.1 | 28.5 | -13.6 | -32.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.035 | 0.056 | 0.076 | -0.023 | -0.056 |
Dividends per Share |